Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Metastases to kidney)
15,166 results
  • 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study. [Journal Article]
  • EJEur J Nucl Med Mol Imaging 2018 Sep 19
  • Sathekge M, Bruchertseifer F, … Morgenstern A
  • CONCLUSIONS: 225Ac-PSMA-617 RLT of chemotherapy-naïve patients with advanced metastatic prostate carcinoma led to a ≥ 90% decline in serum PSA in 82% of patients including 41% of patients with undetectable serum PSA who remained in remission 12 months after therapy. The remarkable therapeutic efficacy reported in this study could be achieved with reduced toxicity to salivary glands due to de-escalation of administered activities in subsequent treatment cycles. This necessitates further exploration for informing clinical practice and clinical trial design.
  • Gamma Knife Radiosurgery for Metastatic Brain Tumors with Exophytic Hemorrhage. [Journal Article]
  • JKJ Korean Neurosurg Soc 2018; 61(5):592-599
  • Park ES, Lee EJ, … Kwon DH
  • CONCLUSIONS: Our experience shows that GKS performed in conjunction with our targeting technique safely and effectively treats hemorrhagic MBTs. The success of this technique may reflect the presence of scattered metastatic tumor cells in the hematoma that do not proliferate owing to the inadequate microenvironment of the hematoma. We suggest that GKS can be a useful treatment option for patients with hemorrhagic MBTs that are not amenable to surgery.
New Search Next